All stocks today
71229 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

Astellas Pharma Inc. revenue reports

Astellas Pharma Inc. financial reports, Astellas Pharma Inc. annual revenue in 2020. When does Astellas Pharma Inc. report revenue?
Add to widgets
Added to widgets

Astellas Pharma Inc. total revenue, net income and dynamics of changes in Euro today

Net revenue of Astellas Pharma Inc. on 31/12/2019 amounted to 338 065 000 000 €. Net income Astellas Pharma Inc. - 61 494 000 000 €. Information about net income is used from open sources. The dynamics of Astellas Pharma Inc. net income fell by -8 515 000 000 €. The assessment of the dynamics of Astellas Pharma Inc. net income was made in comparison with the previous report. Graph of the financial report of Astellas Pharma Inc.. The financial report chart on our website displays information by dates from 31/03/2019 to 31/12/2019. Astellas Pharma Inc. financial report on a graph in real time displays the dynamics, i.e. change in fixed assets of the company.

Report date Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and Change (%)
Comparing current quartal report this year to quartal report last year.
31/12/2019 301 283 528 000 € - 54 803 452 800 € -
30/09/2019 281 918 643 200 € - 62 392 020 800 € -
30/06/2019 297 780 220 800 € - 52 151 241 600 € -
31/03/2019 268 536 384 000 € - 27 386 576 000 € -
Show:
to

Astellas Pharma Inc. financial report charts

Dates of Astellas Pharma Inc. finance reports: 31/03/2019, 30/09/2019, 31/12/2019. The dates of the financial statements are determined by the accounting rules. The latest financial report of Astellas Pharma Inc. is available online for such a date - 31/12/2019. Gross profit Astellas Pharma Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Astellas Pharma Inc. is 255 296 000 000 €

Astellas Pharma Inc. quarterly report dates

Cost of revenue Astellas Pharma Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue Astellas Pharma Inc. is 82 769 000 000 € Total revenue Astellas Pharma Inc. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Astellas Pharma Inc. is 338 065 000 000 € Operating income Astellas Pharma Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Astellas Pharma Inc. is 76 236 000 000 €

Net income Astellas Pharma Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Astellas Pharma Inc. is 61 494 000 000 € Current assets Astellas Pharma Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Astellas Pharma Inc. is 834 150 000 000 € Total assets Astellas Pharma Inc. refers to the total amount of assets owned by a person or entity. Total assets Astellas Pharma Inc. is 1 989 779 000 000 €

  31/12/2019 30/09/2019 30/06/2019 31/03/2019
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
227 519 795 200 € 220 996 211 200 € 234 939 926 400 € 211 197 467 200 €
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
73 763 732 800 € 60 922 432 000 € 62 840 294 400 € 57 338 916 800 €
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
301 283 528 000 € 281 918 643 200 € 297 780 220 800 € 268 536 384 000 €
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
- - - -
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
67 941 523 200 € 76 454 265 600 € 69 348 728 000 € 64 115 601 600 €
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
54 803 452 800 € 62 392 020 800 € 52 151 241 600 € 27 386 576 000 €
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
48 819 936 000 € 45 867 390 400 € 47 685 438 400 € 52 333 937 600 €
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
233 342 004 800 € 205 464 377 600 € 228 431 492 800 € 204 420 782 400 €
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
743 394 480 000 € 762 507 155 200 € 730 899 856 000 € 763 900 100 800 €
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
1 773 291 044 800 € 1 764 412 019 200 € 1 717 370 027 200 € 1 691 183 897 600 €
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
247 398 902 400 € 277 490 270 400 € 231 196 886 400 € 277 229 148 800 €
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
415 350 889 600 € 431 007 491 200 € 413 661 174 400 € 441 820 420 800 €
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
- - - -
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
599 183 169 600 € 609 296 507 200 € 603 630 257 600 € 569 701 382 400 €
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
33.79 % 34.53 % 35.15 % 33.69 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
1 174 107 875 200 € 1 155 115 512 000 € 1 113 739 769 600 € 1 121 482 515 200 €
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
61 163 947 200 € 83 992 926 400 € 6 605 574 400 € 48 970 548 800 €

Last revenue report of Astellas Pharma Inc. was 31/12/2019. According to last financial report total revenue in Astellas Pharma Inc. was 301 283 528 000 Euro and changed by 0% since last year. Net income in Astellas Pharma Inc. was 54 803 452 800 € in last quartal, net income changes to 0%.

Current cash Astellas Pharma Inc. - the sum of all of the cash a company has on the date of report. Current cash Astellas Pharma Inc. is 277 602 000 000 € Current debt Astellas Pharma Inc. is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital. Current debt Astellas Pharma Inc. is 466 058 000 000 € Total debt Astellas Pharma Inc. is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year. Total debt Astellas Pharma Inc. is 672 333 000 000 €

Astellas Pharma Inc. stocks data

Astellas Pharma Inc. financials